Hong Lu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 38

Top Topics

Antimicrobial Resistance

Randomized Controlled Trial

Helicobacter Pylori

Top Venues

Journal of gastroenterology

The Journal of infectious diseases

Therapeutic advances in gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Huang, Shuhan Qiu, Yixian Guo, Jinnan Chen, Meixuan Li, Zhaohui Ding, Wei Zhang, Xiao Liang, Hong Lu
Optimization of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Real-World Evidence Study. Helicobacter 29 (5) (2024)
Chen Zhang, Ya-Bin Qi, Ruo-Bing Hu, Lu Xu, Xiao-Ting Li, Jing Ma, Qiao-Qiao Shao, Mohammed Awadh Abdun, Ishtiaq Ur Rahman, Wen-Jun Shi, Fu-Qiang Li, Jian-Jie Yu, Ming-Kai Yuan, Qi Chen, Hong Lu, Song-Ze Ding
Family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are highly cost-effective in preventing multiple upper gastrointestinal diseases in Chinese population at national level. Helicobacter 29 (3) (2024)
Shuhan Qiu, Yu Huang, Jinnan Chen, Yixian Guo, Meixuan Li, Zhaohui Ding, Xiao Liang, Hong Lu
Vonoprazan-Amoxicillin Dual Therapy With Different Amoxicillin Administration Regimens for Helicobacter pylori Treatment: A Randomized Controlled Trial. Helicobacter 29 (4) (2024)
Yu Huang, Hong Lu
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial. Journal of gastroenterology (2024)
Yu Huang, Hong Lu
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial. Journal of gastroenterology 59 (4) (2024)
Yu Huang, Hong Lu
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial. Journal of gastroenterology 59 (4) (2024)
Yu Huang, Hong Lu
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial. Journal of gastroenterology 59 (4) (2024)
Yue-Hua Han, Wei Zhang, Yu-Ting Wang, Zhi-Juan Xiong, Qin Du, Yong Xie, Hong Lu
Performance evaluation of a novel 14C-urea breath test (solid scintillation) for the diagnosis of helicobacter pylori infection. Medicine 102 (9) (2023)
Wei Zhang, Qian Gui, Jinnan Chen, Dazhong Yu, Wenyu Su, Changqing Zhu, Xiao Liang, Hong Lu
Intravenous metronidazole-, levofloxacin-containing triple therapy for treating patients with Helicobacter pylori-related active peptic ulcer complications: A pilot study. Helicobacter 28 (2) (2023)
Wei Zhang, Qian Gui, Jinnan Chen, Dazhong Yu, Wenyu Su, Changqing Zhu, Xiao Liang, Hong Lu
Intravenous metronidazole-, levofloxacin-containing triple therapy for treating patients with Helicobacter pylori-related active peptic ulcer complications: A pilot study. Helicobacter 28 (2) (2023)
Zhao-Hui Ding, Yu Huang, Jin-Nan Chen, Lai-Sheng Luo, Wei Zhang, Xiao Liang, Hong Lu
A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Wei Zhang, Qian Gui, Jinnan Chen, Dazhong Yu, Wenyu Su, Changqing Zhu, Xiao Liang, Hong Lu
Intravenous metronidazole-, levofloxacin-containing triple therapy for treating patients with Helicobacter pylori-related active peptic ulcer complications: A pilot study. Helicobacter 28 (2) (2023)
Yu Huang, Jinnan Chen, Zhaohui Ding, Xi Chen, Xiao Liang, Xin Zeng, Fei Xu, Yuehua Han, Hong Lu
Minocycline vs. tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial. Journal of gastroenterology (2023)
Wei Zhang, Qian Gui, Jinnan Chen, Dazhong Yu, Wenyu Su, Changqing Zhu, Xiao Liang, Hong Lu
Intravenous metronidazole-, levofloxacin-containing triple therapy for treating patients with Helicobacter pylori-related active peptic ulcer complications: A pilot study. Helicobacter 28 (2) (2023)
Jinnan Chen, Yixian Guo, Yu Huang, Zhaohui Ding, Jing Wang, Ling Xiao, Ping Xu, Yaohua Han, Hong Lu
Rifabutin-containing Triple Therapy versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial. The Journal of infectious diseases (2023)
Yu Huang, Jinnan Chen, Yixian Guo, Zhaohui Ding, Xiao Liang, Wei Zhang, Hanbing Xue, Yunjia Zhao, Xiaobo Li, Hong Lu
Staging of operative link on gastritis assessment and operative link on gastric intestinal metaplasia systems for risk assessment of early gastric cancer: a case-control study. Journal of clinical pathology (2023)
Zhao-Hui Ding, Yu Huang, Jin-Nan Chen, Lai-Sheng Luo, Wei Zhang, Xiao Liang, Hong Lu
A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment. The Journal of antimicrobial chemotherapy (2023)
Yixian Guo, Feng Xie, Xu Liu, Shouyu Ke, Jieqiong Chen, Yi Zhao, Ning Li, Zeyu Wang, Gang Yi, Yanying Shen, Dan Li, Chunchao Zhu, Zizhen Zhang, Gang Zhao, Hong Lu, Bin Li, Wenyi Zhao
Blockade of TNF-α/TNFR2 signalling suppresses colorectal cancer and enhances the efficacy of anti-PD1 immunotherapy by decreasing CCR8+ T regulatory cells. Journal of molecular cell biology (2023)
Jinnan Chen, Yixian Guo, Yu Huang, Zhaohui Ding, Jing Wang, Ling Xiao, Ping Xu, Yaohua Han, Hong Lu
Rifabutin-containing Triple Therapy versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial. The Journal of infectious diseases (2023)
Jinnan Chen, Yixian Guo, Yu Huang, Zhaohui Ding, Jing Wang, Ling Xiao, Ping Xu, Yaohua Han, Hong Lu
Rifabutin-containing Triple Therapy versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial. The Journal of infectious diseases (2023)
Wei Zhang, Qian Gui, Jinnan Chen, Dazhong Yu, Wenyu Su, Changqing Zhu, Xiao Liang, Hong Lu
Intravenous metronidazole-, levofloxacin-containing triple therapy for treating patients with Helicobacter pylori-related active peptic ulcer complications: A pilot study. Helicobacter (2023)
Jinnan Chen, Yixian Guo, Yu Huang, Zhaohui Ding, Jing Wang, Ling Xiao, Ping Xu, Yaohua Han, Hong Lu
Rifabutin-containing Triple Therapy versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial. The Journal of infectious diseases (2023)
Jinnan Chen, Puheng Li, Yu Huang, Yixian Guo, Zhaohui Ding, Hong Lu
Primary Antibiotic Resistance of Helicobacter pylori in Different Regions of China: A Systematic Review and Meta-Analysis. Pathogens (Basel, Switzerland) 11 (7) (2022)
Jing Ma, Miao Yu, Qiao-Qiao Shao, Xue-Chun Yu, Chen Zhang, Jun-Bo Zhao, Lin Yuan, Ya-Bin Qi, Ruo-Bing Hu, Pei-Ru Wei, Wei Xiao, Qi Chen, Bai-Ling Jia, Chuan-Liang Chen, Hong Lu, Song-Ze Ding
Both family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are cost-effective for gastric cancer prevention. Helicobacter 27 (4) (2022)
Yu Huang, Jinnan Chen, Zhaohui Ding, Xiao Liang, Hong Lu
Susceptibility testing alone will not reliably achieve high Helicobacter pylori cure rates: A systematic review and meta-analysis. Journal of gastroenterology and hepatology 37 (7) (2022)
Wei Zhang, Xiao Liang, Xiaoyu Chen, Zhizheng Ge, Hong Lu
Time trends in the prevalence of Helicobacter pylori infection in patients with peptic ulcer disease: a single-center retrospective study in Shanghai. The Journal of international medical research 49 (10) (2021)
Yu Huang, Huiyi Li, Xiaohua Long, Xiao Liang, Hong Lu
Lessons learned from upper gastrointestinal endoscopy in asymptomatic Chinese. Helicobacter 26 (3) (2021)
Song-Ze Ding, Yi-Qi Du, Hong Lu, Wei-Hong Wang, Hong Cheng, Shi-Yao Chen, Min-Hu Chen, Wei-Chang Chen, Ye Chen, Jing-Yuan Fang, Heng-Jun Gao, Ming-Zhou Guo, Ying Han, Xiao-Hua Hou, Fu-Lian Hu, Bo Jiang, Hai-Xing Jiang, Chun-Hui Lan, Jing-Nan Li, Yan Li, Yan-Qing Li, Jie Liu, You-Ming Li, Bin Lyu, You-Yong Lu, Ying-Lei Miao, Yong-Zhan Nie, Jia-Ming Qian, Jian-Qiu Sheng, Cheng-Wei Tang, Fen Wang, Hua-Hong Wang, Jiang-Bin Wang, Jing-Tong Wang, Jun-Ping Wang, Xue-Hong Wang, Kai-Chun Wu, Xing-Zhou Xia, Wei Fen Xie, Yong Xie, Jian-Ming Xu, Chang-Qing Yang, Gui-Bin Yang, Yuan Yuan, Zhi-Rong Zeng, Bing-Yong Zhang, Gui-Ying Zhang, Guo-Xin Zhang, Jiangzhong Zhang, Zhen-Yu Zhang, Peng-Yuan Zheng, Yin Zhu, Xiu-Li Zuo, Li-Ya Zhou, Nong-Hua Lyu, Yun-Sheng Yang, Zhao-Shen Li, null null
Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition). Gut (2021)
Akiko Shiotani, Priya Roy, Hong Lu, David Yates Graham
Helicobacter pylori diagnosis and therapy in the era of antimicrobial stewardship. Therapeutic advances in gastroenterology 14 (2021)
Zhao-Hui Ding, Xiao-Ping Xu, Tian-Rong Wang, Xiao Liang, Zhi-Hua Ran, Hong Lu
The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study. PloS one 16 (3) (2021)
Hong Lu, David Yates Graham
Editorial: not yet time for universal susceptibility-guided first-line Helicobacter pylori treatment-authors' reply. Alimentary pharmacology & therapeutics 50 (3) (2020)
Laisheng Luo, Yingjie Ji, Lou Yu, Yu Huang, Xiao Liang, David Y Graham, Hong Lu
14-Day High-Dose Amoxicillin- and Metronidazole-Containing Triple Therapy With or Without Bismuth as First-Line Helicobacter pylori Treatment. Digestive diseases and sciences 65 (12) (2020)
Jyh-Ming Liou, Peter Malfertheiner, Yi-Chia Lee, Bor-Shyang Sheu, Kentaro Sugano, Hsiu-Chi Cheng, Khay-Guan Yeoh, Ping-I Hsu, Khean-Lee Goh, Varocha Mahachai, Takuji Gotoda, Wei-Lun Chang, Mei-Jyh Chen, Tsung-Hsien Chiang, Chieh-Chang Chen, Chun-Ying Wu, Alex Hwong-Ruey Leow, Jeng-Yih Wu, Deng-Chyang Wu, Tzu-Chan Hong, Hong Lu, Ari Fahrial Syam, Francis Megraud, Francis Ka Leung Chan, Joseph Jy Sung, Jaw-Town Lin, David Yates Graham, Ming-Shiang Wu, Emad M El-Omar, null null
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut 69 (12) (2020)
Laisheng Luo, Yu Huang, Xiao Liang, Yingjie Ji, Lou Yu, Hong Lu
Susceptibility-guided therapy for Helicobacter pylori-infected penicillin-allergic patients: A prospective clinical trial of first-line and rescue therapies. Helicobacter 25 (4) (2020)
David Yates Graham, Hong Lu, Akiko Shiotani
Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance. Journal of gastroenterology and hepatology 36 (5) (2020)
Cai-Ping Gao, Di Zhang, Ting Zhang, Jin-Xia Wang, Sheng-Xi Han, David Yates Graham, Hong Lu
PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis. Helicobacter 25 (4) (2020)
Lou Yu, Laisheng Luo, Xiaohua Long, Xiao Liang, Yingjie Ji, Qi Chen, Yanyan Song, Xiaobo Li, David Y Graham, Hong Lu
Susceptibility-guided therapy for Helicobacter pylori infection treatment failures. Therapeutic advances in gastroenterology 12 (2019)
Qi Chen, Xiaohua Long, Yingjie Ji, Xiao Liang, Dongping Li, Hong Gao, Beili Xu, Ming Liu, Ying Chen, Yunwei Sun, Yan Zhao, Gang Xu, Yanyan Song, Lou Yu, Wei Zhang, Wenzhong Liu, David Yates Graham, Hong Lu
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment. Alimentary pharmacology & therapeutics 49 (11) (2019)